NewsBenzingaReported Earlier, Estrella’s EB103 Dosed Twice Three Weeks Apart In First Dose-Expansion Patient At Recommended Phase II Dose, No Treatment-Related SAEs; Dose-Escalation Delivered 100% Month 1 Complete Response In High-Dose Cohort Reported Earlier, Estrella’s EB103 Dosed Twice Three Weeks Apart In First Dose-Expansion Patient At Recommended Phase II Dose, No Treatment-Related SAEs; Dose-Escalation Delivered 100% Month 1 Complete Response In High-Dose Cohort Benzinga 2026.10.16 06:48 (GMT+0) Open on Benzinga Other news TSMC Stock: The AI Boom Is Bigger And Longer Than Expected (NYSE:TSM) Chamath Palihapitiya Says 6% Treasury Yield Could ‘Run Over’ AI Businesses "AI stock god" Leopold's fund re-entered AI stocks in early September, only to face another sell-off with 7 holdings down 18.3% on average Starwood Property Stock: Why I Got This Wrong (NYSE:STWD) Next Week's Macro Outlook: Fed Enters Blackout Period, US Earnings Season Hits Its Stride T-Mobile Stock: A Major Profit Boost May Be Coming (NASDAQ:TMUS)
"AI stock god" Leopold's fund re-entered AI stocks in early September, only to face another sell-off with 7 holdings down 18.3% on average
